Cancer Genetics

Um estudo internacional envolvendo 56 investigadores e clínicos de nove países, liderado pela cientista Carla Oliveira, do Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S), e publicado na prestigiada revista GUT, definiu novas causas de risco genético de cancro gástrico e mamário e critérios clínicos para os identificar.

A groundbreaking international study has provided critical insights into the role of CTNNA1 gene variants in hereditary diffuse gastric cancer (HDGC), revealing new associations with cancer risk and paving the way for improved genetic testing and clinical management of affected individuals.

The study involved 56 researchers and clinicians from 9 countries, from the European and American continents, led by an i3S team in Porto.

Dolce Campo Real Lisboa, Portugal

14 - 17 July, 2020

Link: https://www.fusion-conferences.com/conference/114
 

Authors and affiliations:

Bruno Silva(1), Richard Pentz(1), Ana Margarida Figueira(1), Rajika Arora(1), Yong Woo Lee(1), Charlotte Hodson(2), Harry Wischnewski(3), Andrew J. Deans(2,4), and Claus M. Azzalin(1)

(1)Instituto de Medicina Molecular João Lobo Antunes (iMM), Faculdade de Medicina da Universidade de Lisboa, Lisbon, 1649-028, Portugal

(2)Genome Stability Unit, St. Vincent’s Institute of Medical Research, Fitzroy, 3065, VIC, Australia

i3S/Ipatimup, Meeting room 2, Porto Portugal

29 May - 01 June, 2017

See more informations here: https://www.ipatimup.pt/Site/ActivityView.aspx?ActivityId=2990

i3S/Ipatimup, Meeting room 2, Porto Portugal

29 May - 01 June, 2017

See more informations here: https://www.ipatimup.pt/Site/ActivityView.aspx?ActivityId=2990

University Residential Centre of Bertinoro, Bertinoro, Italy

10 - 13 April, 2016

See more informations here: http://www.ceub.it/default.asp?id_c=510&id=436#.Vq-V609OfAV

University Residential Centre of Bertinoro, Bertinoro, Italy

10 - 13 April, 2016

See more informations here: http://www.ceub.it/default.asp?id_c=510&id=436#.Vq-V609OfAV